Clinical Trial Update: Glucocorticoid Receptor Antagonism in Subclinical Cushings [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update investigating glucocorticoid receptor antagonism for subclinical Cushing's syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Subclinical Cushing Syndrome

Snippet

Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust | Conditions: Subclinical Cushing's | Phase 1, Phase 2 | Status: COMPLETED